Skip to main content

Table 1

From: PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial

  Wk 52 Wk 104
Ash score (n = 47), median (IQR) 0.00 (-8.70: 4.00) 0.50 (-7.50: 12.00)
Poznanski score (n = 33), median (IQR) 0.30 (-0.02: 1.03) 0.17 (0.01: 1.04)
ACR Pedi 70 (n = 112), n/N (%) 92/106 (86.8) 57/65 (87.7)
ACR Pedi 90 (n = 112), n/N (%) 67/106 (63.2) 46/65 (70.8)